August 24, 2009
AstraZeneca K.K. (AZ) and Astellas Pharma Inc. announced on August 4 that AstraZeneca AB and Astellas have concluded a copromotion agreement for the inhalant combination of budesonide and formoterol (overseas brand name: Symbicort) for the treatment of bronchial asthma in...read more